Zhejiang Hisun Pharmaceutical Hits Day Low of CNY 9.71 Amid Price Pressure

Zhejiang Hisun Pharmaceutical Co., Ltd. experienced a notable decline in its stock performance on June 16, 2026, with a decrease of 3.84%. The stock reached an intraday low of CNY 9.71, reflecting a challenging day for the company within the pharmaceuticals and biotechnology sector. In comparison to the broader market, the China Shanghai Composite index saw a modest decline of 0.11% on the same day. Over the past week, Zhejiang Hisun has shown a positive trend, gaining 2.95%, while its performance over the past month has been less favorable, with a drop of 12.54%. Year-to-date, the stock has decreased by 1.31%, contrasting with the Shanghai Composite's gain of 3.1%. Over a longer horizon, the stock has faced significant challenges, with a three-year decline of 14.39% and a five-year drop of 28.13%. Despite these fluctuations, the company maintains a market capitalization of CNY 10,432 million and a price-to-earnings ratio of 14.00, indicating its position as a large-cap player in the industry.